Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 22.89x is in line with its estimated 1-year average of 25.27x, near the low end of its estimated 1-year range (21.99x–27.63x).
As of 2026-10-06T21:23:34.260Z.
Calculation as of: 2026-10-06T21:23:34.260Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e34e8fdf56cc8068b10795b2cd23ca1cf428d99faa8853e43d8e56f6a2fe063d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
22.89x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.69x
median of 217 covered companies
CURRENT VS SECTOR MEDIAN
+45.89%
vs the sector median at left
Market Cap
$422.86M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$424.10M
EV/EBITDA Ratio
N/A
TTM Avg
74.72x
3Y Avg
37.71x
5Y Avg
26.88x
Market Cap
$419.87M
EV/EBITDA Ratio
N/A
TTM Avg
16.39x
3Y Avg
16.39x
5Y Avg
16.39x
Market Cap
$426.51M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.27M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | $422.72M | 22.89x | N/A | N/A | N/A |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | N/A | 74.72x | 37.71x | 26.88x |
| Prothena Corporation plc (PRTA)vs › | $419.87M | N/A | 16.39x | 16.39x | 16.39x |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | N/A | N/A | N/A | N/A |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | N/A | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
At 22.9, EV/EBITDA is below its estimated 1-year median — higher than 8% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
22.0
median
25.7
estimated 1-year high
27.6
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 22.64x |
| 2026-10-02 | 22.16x |
| 2026-10-01 | 21.99x |
| 2026-09-30 | 22.76x |
| 2026-09-29 | 23.62x |
| 2026-09-28 | 23.93x |
| 2026-09-25 | 24.40x |
| 2026-09-24 | 24.14x |
| 2026-09-23 | 24.31x |
| 2026-09-22 | 24.83x |
| 2026-09-21 | 24.18x |
| 2026-09-18 | 23.80x |
| 2026-09-17 | 23.58x |
| 2026-09-16 | 23.54x |
| 2026-09-15 | 23.80x |
| 2026-09-14 | 24.44x |
| 2026-09-11 | 23.93x |
| 2026-09-10 | 24.44x |
| 2026-09-09 | 24.74x |
| 2026-09-08 | 25.13x |
| 2026-09-04 | 25.99x |
| 2026-09-03 | 26.12x |
| 2026-09-02 | 26.08x |
| 2026-09-01 | 25.99x |
| 2026-08-31 | 26.29x |
| 2026-08-28 | 26.38x |
| 2026-08-27 | 26.29x |
| 2026-08-26 | 26.59x |
| 2026-08-25 | 27.63x |
| 2026-08-24 | 26.94x |
| 2026-08-21 | 27.45x |
| 2026-08-20 | 26.72x |
| 2026-08-19 | 27.41x |
| 2026-08-18 | 25.86x |
| 2026-08-17 | 25.90x |
| 2026-08-14 | 26.72x |
| 2026-08-13 | 26.85x |
| 2026-08-12 | 26.76x |
| 2026-08-11 | 27.20x |
| 2026-08-10 | 25.65x |
| 2026-08-07 | 26.29x |
| 2026-08-06 | 25.73x |
| 2026-08-05 | 25.69x |
| 2026-08-04 | 26.59x |
| 2026-08-03 | 26.59x |
| 2026-07-31 | 26.16x |
| 2026-07-30 | 24.70x |
| 2026-07-29 | 23.80x |